Lymphoma is a complex set of diseases that can affect any organ system and I am drawn to the challenge of helping patients battle this challenging disease. Treating a serious illness like lymphoma needs a meticulous review of all aspects of the case, critical thinking, effective communication, while also providing the highest level of compassionate care for patients. While it's important to understand every detail of the disease, I also really focus on understanding the patient and their treatment goals to develop an individualized treatment plan that would improve their quality of life. I strive to ensure that my patients have access to cutting-edge novel therapies through clinical trials. Hence, apart from patient care, I am also involved in clinical research testing of new effective drug combinations in lymphoma.
Sundaram S, Moore E, Ayyappan S, Covut F, Tomlinson B, Creger R, Malek E, Metheny L, Cooper B, Lazarus H, de Lima M, Caimi PF, Effect of Histological Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular lymphoma in the rituximab era; Blood 2017 130:2775
Sundaram S, Dharmavaram G, Tomlinson B, Creger R, Malek E, Metheny L, Cooper B, Lazarus H, de Lima M, Caimi PF, Early Cardiovascular Toxicity with Treatment of Follicular Lymphoma Is Associated with Shorter Overall Survival; Blood 2017 130:2776
Haddad H, Sundaram S, Magro C, Gergis U. Eosinophilic fasciitis as a paraneoplastic syndrome, a case report and review of the literature Hematol Oncol Stem Cell Ther. 2014 Feb 10
Dosani T, Gerson S, Sundaram S, Hoffman G, Covut F, Downes K, Maitta R, deLima M, Malek E, Plerixafor overcomes Lenalidomide- Associated Stem Cell Collection Failure and Affects Collected Myeloid and Erythroid Progenitors; Blood 2017 130:1922
Sundaram, S, Edwin N, Rogers J, Silver B, McCrae K. “Risk of Arterial and Venous Thrombosis in Patients with “Indeterminate” Lupus Anticoagulant Testing” Blood 2014 124:4249